Wednesday, June 8, 2016
Cancer MoonShot 2020 Targets Head, Neck Cancers
Cancer MoonShot 2020, the cancer treatment and collaboration group being led by Culver City-based NantHealth, said this morning that it has created a new group specifically focused on head and neck cancer. The new Head and Neck Working Group will specifically focus on cancer-directed immunotherapy treatments for head and neck cancer, and includes scientists, physicians, and oncology professors. The group said the group will develop clinical trial protocols, carefully studying elements such as standard of care, GPS Cancer test factors, patient selection, and appropriate combination immunotherapy approaches.